Investegate |BioNTech SE Announcements | BioNTech SE: Pfizer and BioNTech Receive Authorization in the European Union for COVID-19 Vaccine
Pfizer and BioNTech Receive Authorization in the European Union for COVID-19 Vaccine COMIRNATY ® (also known as BNT162b2) receives conditional marketing authorization from the European Commission; this milestone represents a global joint effort to advance the first authorized mRNA vaccine Pfizer and BioNTech are ready to immediately ship initial doses to the 27 EU member states Pfizer and BioNTech previously announced an agreement with the European Commission to supply 200 million vaccine doses to EU member states; the EU also has an option to purchase an additional 100 million doses in 20...
Source: investegate.co.uk